These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 22715242)

  • 1. Inappropriate mode switching in a dual-chamber defibrillator system: what is the mechanism?
    Williams ES; Knapp MI; Patton KK
    Circ Arrhythm Electrophysiol; 2012 Jun; 5(3):e67-8. PubMed ID: 22715242
    [No Abstract]   [Full Text] [Related]  

  • 2. Arrhythmogenic right ventricular dysplasia and the implantable cardioverter-defibrillator: a case report and review of the literature.
    Cohen TJ; Zadeh H; Fruauff A; Klein J
    J Invasive Cardiol; 2000 Aug; 12(8):422-4. PubMed ID: 10953107
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of a coronary sinus lead and biventricular ICD to correct a sensing abnormality in a patient with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Bilchick KC; Judge DP; Calkins H; Marine JE
    J Cardiovasc Electrophysiol; 2006 Mar; 17(3):317-20. PubMed ID: 16643408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of electrophysiologic properties of the A-V node and His-Purkinje system in triggering inappropriate ICD discharges in a patient with arrhythmogenic right ventricular dysplasia. Effective treatment with RF ablation].
    Włodarska EK; Szumowski Ł; Przybylski A; Konka M; Walczak E; Zaleska T; Kepski R; Urbanek P; Derejko P; Ruzyłło W; Szwed H; Hoffman P; Walczak F
    Kardiol Pol; 2004 Feb; 60(2):178-85. PubMed ID: 15116170
    [No Abstract]   [Full Text] [Related]  

  • 5. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.
    Corrado D; Calkins H; Link MS; Leoni L; Favale S; Bevilacqua M; Basso C; Ward D; Boriani G; Ricci R; Piccini JP; Dalal D; Santini M; Buja G; Iliceto S; Estes NA; Wichter T; McKenna WJ; Thiene G; Marcus FI
    Circulation; 2010 Sep; 122(12):1144-52. PubMed ID: 20823389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantation of a biventricular defibrillator in a borderline case of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Coppola G; Quagliana A; Ciaramitaro G; Corrado E; Inciardi R; Rotolo A; Evola S; Farinella M; Novo G; Assennato P
    Minerva Cardioangiol; 2014 Dec; 62(6):497-9. PubMed ID: 25420502
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequential Inappropriate Subcutaneous Implantable Cardioverter-Defibrillator Shocks: Pro-Arrhythmia Followed by Failure to Rescue.
    Torres CA; Helguera ME; Pinski SL; Baez-Escudero JL
    JACC Clin Electrophysiol; 2017 Jul; 3(7):782-784. PubMed ID: 29759545
    [No Abstract]   [Full Text] [Related]  

  • 8. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inappropriate shocks by subcutaneous defibrillator in a patient with arrhythmogenic right ventricular cardiomyopathy: problem fixed.
    Allocca G; Sitta N; Turiano G
    Europace; 2015 Jul; 17(7):1067. PubMed ID: 25842275
    [No Abstract]   [Full Text] [Related]  

  • 10. A particular malignant case of untreatable ventricular arrhythmias in arrhythmogenic cardiomyopathy.
    Molina-Martin de Nicolas J; Fontenla Cerezuela A; Diaz Anton B; Rubio Alonso B; Salgado Aranda R; Salguero Bodes R; Lopez Gil M; Arribas Ynsaurriaga F
    Int J Cardiol; 2015 Mar; 182():307-8. PubMed ID: 25585375
    [No Abstract]   [Full Text] [Related]  

  • 11. Subcutaneous Implantable Cardioverter-Defibrillator and Arrhythmogenic Right Ventricular Cardiomyopathy: The Importance of Repeat ECG Screening During Exercise Test.
    Migliore F; Bertaglia E; Zorzi A; Corrado D
    JACC Clin Electrophysiol; 2017 Jul; 3(7):785-786. PubMed ID: 29759546
    [No Abstract]   [Full Text] [Related]  

  • 12. Pronounced epsilon waves in arrhythmogenic right ventricular dysplasia.
    Alter P; Grimm W
    J Cardiovasc Electrophysiol; 2004 Feb; 15(2):248. PubMed ID: 15028061
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical study of 39 Chinese patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Ma KJ; Li N; Wang HT; Chu JM; Fang PH; Yao Y; Ma J; Hua W; Zhang S; Wang FZ; Li Z; Pu JL
    Chin Med J (Engl); 2009 May; 122(10):1133-8. PubMed ID: 19493458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients.
    Wichter T; Paul M; Wollmann C; Acil T; Gerdes P; Ashraf O; Tjan TD; Soeparwata R; Block M; Borggrefe M; Scheld HH; Breithardt G; Böcker D
    Circulation; 2004 Mar; 109(12):1503-8. PubMed ID: 15007002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wide QRS Tachycardia in a young patient.
    Hariman RJ; Khin MM; Zoble RG
    Arch Intern Med; 2012 Apr; 172(7):537; discussion 538-9. PubMed ID: 22493460
    [No Abstract]   [Full Text] [Related]  

  • 16. Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: a role for genotyping in decision-making?
    Wichter T; Breithardt G
    J Am Coll Cardiol; 2005 Feb; 45(3):409-11. PubMed ID: 15680720
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of sudden cardiac deaths in arrhythmogenic right ventricular cardiomyopathy: how to evaluate risk and when to implant a cardioverter-defibrillator?
    Woźniak O; Włodarska EK
    Cardiol J; 2009; 16(6):588-91. PubMed ID: 19950101
    [No Abstract]   [Full Text] [Related]  

  • 18. Palpitations: an annoyance that may require clairvoyance.
    Reagan BW; Huang RL; Clair WK
    Circulation; 2012 Feb; 125(7):958-65. PubMed ID: 22354976
    [No Abstract]   [Full Text] [Related]  

  • 19. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Roguin A; Bomma CS; Nasir K; Tandri H; Tichnell C; James C; Rutberg J; Crosson J; Spevak PJ; Berger RD; Halperin HR; Calkins H
    J Am Coll Cardiol; 2004 May; 43(10):1843-52. PubMed ID: 15145110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated left ventricular arrhythmogenic dysplasia.
    Galvão Braga C; Silva P; Salgado A; Magalhães S; Themudo R
    Eur Heart J Cardiovasc Imaging; 2014 Aug; 15(8):907. PubMed ID: 24562184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.